Last reviewed · How we verify

NCT06360549

Effect of Percutaneous Acupoint Electrical Stimulation on Delirium

Recruiting now NA Last updated 11 April 2024
What this trial tests

NA trial testing Transcutaneous Electrical Acupoint Stimulation in Delirium, Postoperative in 238 participants. Currently enrolling.

Timeline
1 March 2024
Primary endpoint
30 December 2024
30 June 2025

Quick facts

Lead sponsorQin Zhang
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment238
Start date1 March 2024
Primary completion30 December 2024
Estimated completion30 June 2025
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Qin Zhang

Who can join

18 and older, any sex, with Delirium, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a multicenter, prospective, randomized controlled clinical trial that aims to observe the impact of Transcutaneous Electrical Acupoint Stimulation (TEAS) on plasma TK/MMP3 in a randomized controlled setting. The intervention group received percutaneous acupoint electrical stimulation, whereas the control group underwent conventional treatment. The primary objective is to enhance the management of postoperative delirium, specifically focusing on the occurrence and severity of delirium following thoracoscopic pulmonary resection. Additionally, various perioperative inflammatory markers, cognitive function, recovery quality, pain levels, anxiety, sleep patterns, postoperative complications, and overall hospital stay duration were monitored to elucidate the mechanisms through which percutaneous acupoint electrical stimulation improves postoperative delirium.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Transcutaneous Electrical Acupoint Stimulation

Trials testing the same drug.

Other recruiting trials for Delirium, Postoperative

Currently open trials in the same condition.

Other Qin Zhang trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06360549.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing